Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Toft

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
The Lancet. Neurology|November 9, 2019
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesMike A Nalls, Cornelis Blauwendraat, Costanza L Vallerga, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Neurology|September 11, 2015
Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseLisa Wang, Jan O Aasly, Grazia Annesi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 2020
Differences in the Presentation and Progression of Parkinson's Disease by SexHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
The Journal of Clinical Investigation|June 11, 2026
Biallelic inactivating variants in the chromatin remodeler DMAP1 cause a syndromic neurodevelopmental disorderQin Wang, Andrew K Sobering, Christian Tirrito, et al.
Brain : a Journal of Neurology|November 23, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementiaCornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Frontiers in Neurorobotics|January 22, 2024
Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocolIra H Haraldsen, Christoffer Hatlestad-Hall, Camillo Marra, et al.
NPJ Parkinson'S Disease|May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onsetKatalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
Journal of Parkinson'S Disease|October 11, 2021
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's DiseaseCloé Domenighetti, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, et al.
Neurology|August 15, 2022
Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD ConsortiumSandeep Grover, Ashwin Ashok Kumar Sreelatha, Lasse Pihlstrom, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
The Lancet. Neurology|November 9, 2019
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studiesMike A Nalls, Cornelis Blauwendraat, Costanza L Vallerga, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
Neurology|September 11, 2015
Large-scale assessment of polyglutamine repeat expansions in Parkinson diseaseLisa Wang, Jan O Aasly, Grazia Annesi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 2020
Differences in the Presentation and Progression of Parkinson's Disease by SexHirotaka Iwaki, Cornelis Blauwendraat, Hampton L Leonard, et al.
The Journal of Clinical Investigation|June 11, 2026
Biallelic inactivating variants in the chromatin remodeler DMAP1 cause a syndromic neurodevelopmental disorderQin Wang, Andrew K Sobering, Christian Tirrito, et al.
Brain : a Journal of Neurology|November 23, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementiaCornelis Blauwendraat, Xylena Reed, Lynne Krohn, et al.
Frontiers in Neurorobotics|January 22, 2024
Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocolIra H Haraldsen, Christoffer Hatlestad-Hall, Camillo Marra, et al.
NPJ Parkinson'S Disease|May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onsetKatalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
Journal of Parkinson'S Disease|October 11, 2021
Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's DiseaseCloé Domenighetti, Pierre-Emmanuel Sugier, Ashwin Ashok Kumar Sreelatha, et al.
Neurology|August 15, 2022
Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD ConsortiumSandeep Grover, Ashwin Ashok Kumar Sreelatha, Lasse Pihlstrom, et al.
Pageof 13